Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.The US Food and Drug Administration (FDA) has approved Warner Chilcott's new oral contraceptive MINASTRIN 24 FE.
Subscribe to our email newsletter
MINASTRIN 24 FE (norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules) is indicated for use by females of reproductive age for the prevention of pregnancy.
A third party manufactures MINASTRIN 24 FE for Warner Chilcott.
Specialty pharmaceutical company Warner Chilcott is focused on the women’s healthcare, gastroenterology, urology and dermatology areas of the branded pharmaceuticals market, mainly in North America.